Thursday, May 30, 2019

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

from Moneycontrol Business News http://bit.ly/2Kc0mlT

No comments:

Post a Comment

End of a love affair: news media quit X over 'disinformation'

Major news outlets are leaving social media platform X. They say the platform is enabling the spread of disinformation. X's owner is Elo...